Tech Company Financing Transactions

C Ray Therapeutics Funding Round

C Ray Therapeutics secured a $100 million Series A funding round on 11/18/2024. Investors included Shenzhen Capital, 3SBio and GL Ventures.

Transaction Overview

Company Name
Announced On
11/18/2024
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
No. 198, Haida Road, Wenjiang District
Chengdu, Undisclosed
China
Email Address
Not Recorded
Overview
We focus on providing full-process, integrated services for radiopharmaceuticals from non-clinical to clinical transformation. Tongrui Bio is committed to becoming an open CRDMO service platform for the industry's "industry-university-research-application" to empower and promote the development of the radiopharmaceutical industry.
Profile
C Ray Therapeutics LinkedIn Company Profile
Social Media
C Ray Therapeutics Company Twitter Account
Company News
C Ray Therapeutics News
Facebook
C Ray Therapeutics on Facebook
YouTube
C Ray Therapeutics on YouTube

Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/18/2024: Revisto venture capital transaction
Next: 11/18/2024: Zenflow venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary